Towfic, Fadi
Bristol-Myers Squibb (United States)
4 papers on CoChatORCID 0000-0001-6756-647X
Most cited papers
- Verified
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Walker, B. A., Mavrommatis, K., Wardell, C. P., Ashby, T. C., Bauer, M., Davies, F. E., Rosenthal, A., Wang, H., Qu, P., Hoering, A., et al. (2018) · Blood
Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia Research
Cited by 475
- Verified
Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
Bjorklund, C. C., Kang, J., Amatangelo, M., Polonskaia, A., Katz, M., Chiu, H., Couto, S., Wang, M., Ren, Y., Ortiz, M., et al. (2020) · Leukemia
Multiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors
Cited by 205
- Verified
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma
Gooding, S., Ansari-Pour, N., Towfic, F., Ortiz Estévez, M., Chamberlain, P. P., Tsai, K.-T., Flynt, E., Hirst, M., Rozelle, D., Dhiman, P., et al. (2021) · Blood
Multiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors
Cited by 172
- Verified
Genome-wide siRNA screen for mediators of NF-κB activation
Gewurz, B. E., Towfic, F., Mar, J. C., Shinners, N. P., Takasaki, K., Zhao, B., Cahir-McFarland, E. D., Quackenbush, J., Xavier, R. J., & Kieff, E. (2012) · Proceedings of the National Academy of Sciences
NF-κB Signaling PathwaysSignaling Pathways in Disease
Cited by 108
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free